Steroids and macular edema from retinal vein occlusion

European Journal of Ophthalmology

Volumn 21, Issue SUPPL.6, 2011, Pages 37-44

  Glacet Bernard, Agnès ^a   Coscas, Gabriel ^a   Zourdani, Alain ^a   Soubrane, Gisèle ^a   Souied, Eric H ^a  

^a HENRI MONDOR HOSPITAL   (France)

Author keywords

Anti VEGF; Dexamethasone; Grid laser treatment; Intravitreous device; Macular edema; Retinal vein occlusion; Steroids; Triamcinolone

Indexed keywords

BEVACIZUMAB; DEXAMETHASONE; DRUG CARRIER; PEGAPTANIB; RANIBIZUMAB; STEROID; TRIAMCINOLONE; VASCULOTROPIN INHIBITOR;

ARTICLE; BRANCH RETINAL VEIN OCCLUSION; CATARACT; CENTRAL RETINA VEIN OCCLUSION; DRUG DELIVERY SYSTEM; DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG FORMULATION; DRUG INDICATION; DRUG RESPONSE; DRUG SAFETY; ENDOPHTHALMITIS; HUMAN; INFECTION; INTRAOCULAR HYPERTENSION; INTRAOCULAR PRESSURE; LASER COAGULATION; MULTICENTER STUDY (TOPIC); OPEN ANGLE GLAUCOMA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RETINA MACULA EDEMA; SIDE EFFECT; SLOW RELEASE FORMULATION; SUSTAINED RELEASE PREPARATION; UNSPECIFIED SIDE EFFECT; VISUAL ACUITY; VISUAL IMPAIRMENT;

ANGIOGENESIS INHIBITORS; ANTI-INFLAMMATORY AGENTS; CLINICAL TRIALS AS TOPIC; DELAYED-ACTION PREPARATIONS; DRUG IMPLANTS; GLUCOCORTICOIDS; HUMANS; INTRAVITREAL INJECTIONS; MACULAR EDEMA; RETINAL VEIN OCCLUSION; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 79961014912     PISSN: 11206721     EISSN: None     Source Type: Journal    
DOI: 10.5301/EJO.2010.6053     Document Type: Article

References (24)

1. Coscas G, Dhermy P. Occlusions Veineuses Rétiniennes: Rapport de la Société Française d'Ophtalmologie. Paris: Masson, 1978; 33-46.
2. Hayreh SS, Hayreh MS. Hemi-central retinal vein occlusion: pathogenesis, clinical features, and natural history. Arch Ophthalmol 1980; 98: 1600-9.
3. Glacet-Bernard A, Coscas G, Chabanel A, Zourdani A, Lelong F, Samama MM. Prognostic factors for retinal vein occlusion: prospective study of 175 cases. Ophthalmology 1996; 103: 551-60.
4. Campochiaro PA, Choy DF, Do DV, et al. Monitoring ocular drug therapy by analysis of aqueous samples. Ophthalmology 2009; 116: 2158-64.
5. The Branch Vein Occlusion Study Group. Argon laser photo-coagulation for macular edema in branch vein occlusion. Am J Ophthalmol 1984; 98: 271-82.
6. Mandelcorn MS, Nrusimhadevara RK. Internal limiting membrane peeling for decompression of macular edema in retinal vein occlusion: a report of 14 cases. Retina 2004; 24: 348-55.
7. Kohner EM, Laatikainen L, Oughton J. The management of central retinal vein occlusion. Ophthalmology 1983; 90: 484-7.
8. Jonas JB, Kreissig I, Degenring RF. Intravitreal triamcinolone acetonide as treatment of macular edema in central retinal vein occlusion. Graefes Arch Clin Exp Ophthalmol 2002; 240: 782-3.
9. Ip MS, Kumar KS. Intravitreous triamcinolone acetonide as treatment for macular edema from central retinal vein occlusion. Arch Ophthalmol 2002; 120: 1217-9.
10. Park CH, Jaffe GJ, Fekrat S. Intravitreal triamcinolone acetonide in eyes with cystoid macular edema associated with central retinal vein occlusion. Am J Ophthalmol 2003; 136: 419-25.
11. Roth DB, Chieh J, Spirn MJ, Green SN, Yarian DL, Chaudhry NA. Noninfectious endophthalmitis associated with intravitreal triamcinolone injection. Arch Ophthalmol 2003; 121: 1279-82.
12. Angulo Bocco MC, Glacet-Bernard A, Zourdani A, Coscas G, Soubrane G. Injection intra-vitréenne: évaluation rétrospective de la technique et des complications d. une série de 2028 injections. J Fr Ophtalmol 2008; 31: 693-8.
13. Jonas JB, Akkoyun I, Kamppeter B, Kreissig I, Degenring RF. Intravitreal triamcinolone acetonide for treatment of central retinal vein occlusion. Eur J Ophthalmol 2005; 15: 751-8.
14. Scott IU, Ip MS, VanVeldhuisen PC, et al, SCORE Study Research Group. A randomized trial comparing the efficacy and safety of intravitreal triamcinolone with standard care to treat vision loss associated with macular edema secondary to branch retinal vein occlusion: the Standard Care vs Corticosteroid for Retinal Vein Occlusion (SCORE) study report 6. Arch Ophthalmol 2009; 127: 1115-28.
15. Ip MS, Scott IU, VanVeldhuisen PC, et al, SCORE Study Research Group. A randomized trial comparing the efficacy and safety of intravitreal triamcinolone with observation to treat vision loss associated with macular edema secondary to central retinal vein occlusion: the Standard Care vs Corticosteroid for Retinal Vein Occlusion (SCORE) study report 5. Arch Ophthalmol 2009; 127: 1101-14.
16. Haller JA, Bandello F, Belfort R Jr, et al. Randomized, shamcontrolled trial of dexamethasone intravitreal implant in patients with macular edema due to retinal vein occlusion. Ophthalmology 2010; 117: 1134-46.
17. Jaissle GB, Ziemssen F, Petermeier K, et al. [Bevacizumab for treatment of macular edema secondary to retinal vein occlusion.] Ophthalmologe 2006; 103: 471-5.
18. Iturralde D, Spaide RF, Meyerle CB, et al. Intravitreal bevacizumab (Avastin) treatment of macular edema in central retinal vein occlusion: a short-term study. Retina 2006; 26: 279-84.
19. Iliev ME, Domig D, Wolf-Schnurrbursch U, Wolf S, Sarra GM. Intravitreal bevacizumab (Avastin) in the treatment of neovascular glaucoma. Am J Ophthalmol 2006; 142: 1054-6.
20. Ferrara DC, Koizumi H, Spaide RF. Early bevacizumab treatment of central retinal vein occlusion. Am J Ophthalmol 2007; 144: 864-71.
21. Pournaras JA, Nguyen C, Vaudaux JD, Konstantinidis L, Ambresin A, Wolfensberger T. Treatment of central retinal vein occlusion-related macular edema with intravitreal bevacizumab (Avastin): preliminary results. Klin Monbl Augenheilkd 2008; 225: 397-400.
22. Wu L, Arevalo JF, Berrocal MH, et al. Comparison of two doses of intravitreal bevacizumab as primary treatment for macular edema secondary to branch retinal vein occlusions: results of the Pan American Collaborative Retina Study Group at 24 months. Retina 2009; 29: 1396-403.
23. Brown DM, Campochiaro PA, Singh RP, et al. Ranibizumab for macular edema following central retinal vein occlusion: six-month primary end point results of a phase III study. Ophthalmology 2010; 117: 1124-33.
24. Campochiaro PA, Heier JS, Feiner L, et al. Ranibizumab for macular edema following branch retinal vein occlusion: sixmonth primary end point results of a phase III study. Ophthalmology 2010; 117: 1102-12.